Viewing StudyNCT00030355

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-05 @ 11:26 AM
Last Modification Date: 2024-10-26 @ 9:07 AM
Study NCT ID: NCT00030355
Status: WITHDRAWN
Last Update Posted: 2013-03-22
First Post: 2002-02-14
Brief Title: Homoharringtonine in Treating Patients With Refractory Acute Promyelocytic Leukemia
Sponsor: National Cancer Institute NCI
Organization: National Cancer Institute NCI
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Leukemia
Keywords:
Name View
adult acute myeloid leukemia with t1517q22q12 View
recurrent childhood acute myeloid leukemia View
recurrent adult acute myeloid leukemia View
adult acute promyelocytic leukemia M3 View
childhood acute promyelocytic leukemia M3 View